Actelion Pharmaceuticals Ltd

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Actelion Pharmaceuticals Ltd Company Summary

COMPANY DATA

	Homepage	www.actelion.com

---

Key Developments: Actelion Pharmaceuticals Ltd

	Actelion Pharmaceuticals Ltd (VTX:ATLN) Actelion's First-in-class Selective S1P1 Receptor Agonist To Enter Phase II Clinical Development NOV 13, 2008 16:03 - Article Views: 343 Actelion Pharmaceuticals Ltd (VTX:ATLN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Actelion Pharmaceuticals Ltd (SWF:ATLN) Actelion Announces 9-months Results For 2008 OCT 21, 2008 16:03 - Article Views: 339 Actelion Pharmaceuticals Ltd (SWF:ATLN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Total net revenues of CHF 1,069.6 million, up 21 percent in local currencies and 13 percent in Swiss Francs - Tracleer® sales of CHF 945.8 million, up 21 percent in local currencies and 12 percent in Swiss Francs - Cash EBIT of CHF 355.6 million, up 18 percent in local currencies and 2 percent in Swiss Francs - Strong cash generation enables full funding of maturing pipeline - Upgraded 2008 guidance
	Actelion Pharmaceuticals Ltd (SWF:ATLN) Actelion To Discuss Financial 9 Month Results 2008 With Development pipeline Update OCT 18, 2008 01:37 - Article Views: 225 Actelion Pharmaceuticals Ltd (SWF:ATLN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Actelion senior management to host Q & A session.
	Actelion Pharmaceuticals Ltd (SWF:ATLN) Actelion Included In The Swiss Market Index SMI SEP 22, 2008 15:03 - Article Views: 758 Actelion Pharmaceuticals Ltd (SWF:ATLN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Tracleer® (bosentan) Receives EU Approval For Treatment Of Patients With Mildly Symptomatic Pulmonary Arterial Hypertension AUG 5, 2008 13:41 - Article Views: 318 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Actelion Announces Half Year Financial Results 2008 JULY 22, 2008 15:03 - Article Views: 1,341 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Total net revenues of CHF 676.0 million - Product sales up 18 percent in local currencies compared to H1 2007 - Tracleer® sales of CHF 605.2 million - Cash EBIT of CHF 190.8 million - Multiple Phase III studies on track - Substantial impact from Actelion/GSK orexin receptor antagonist collaboration to start immediately in H2 2008
	Actelion To Discuss Half Year Financial Results 2008 JULY 19, 2008 01:37 - Article Views: 333 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Actelion senior management to host Q & A session
	Actelion And GlaxoSmithKline Enter Into Exclusive Collaboration To Realise The Full Potential Of Almorexant In Sleep Disorders And Beyond JULY 14, 2008 15:09 - Article Views: 1,082 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Actelion and GlaxoSmithKline (GSK) to potentially co-develop and co-commercialise other orexin receptor antagonists
	Invitation To Investor Webcast/Conference Call JULY 14, 2008 15:09 - Article Views: 206 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Actelion and GlaxoSmithKline enter into exclusive collaboration to realize the full potential of almorexant in sleep disorders and beyond
	Actelion To Join The SMI (Swiss Market Index) JULY 9, 2008 02:17 - Article Views: 324 Actelion Pharmaceuticals Ltd (OTC:ALIOF) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

168 COMPANY PROFILE VIEWS

This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 4) (Since Published: 168)